Neuberger Berman Group’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-686,449	Closed	-$14.4M	–	1812
2022 Q3	$14.4M	Buy	686,449 +36,348	+6%	+$1.01M	0.02%	657
2022 Q2	$20.2M	Buy	650,101 +7,070	+1%	+$241K	0.02%	621
2022 Q1	$26.4M	Sell	643,031 -3,364	-0.5%	-$148K	0.02%	608
2021 Q4	$27.8M	Sell	646,395 -2,662,667	-80%	-$120M	0.02%	608
2021 Q3	$165M	Sell	3,309,062 -109,544	-3%	-$6.63M	0.14%	214
2021 Q2	$214M	Buy	3,418,606 +213,050	+7%	+$13.7M	0.19%	154
2021 Q1	$297M	Sell	3,205,556 -5,793	-0.2%	-$593K	0.28%	83
2020 Q4	$287M	Buy	3,211,349 +274,955	+9%	+$25.2M	0.3%	81
2020 Q3	$303M	Sell	2,936,394 -52,079	-2%	-$5.61M	0.36%	64
2020 Q2	$236M	Buy	2,988,473 +635,676	+27%	+$47.4M	0.29%	87
2020 Q1	$136M	Sell	2,352,797 -98,040	-4%	-$5.65M	0.21%	136
2019 Q4	$132M	Buy	2,450,837 +19,203	+0.8%	+$1.04M	0.15%	198
2019 Q3	$127M	Buy	2,431,634 +215,081	+10%	+$10M	0.16%	187
2019 Q2	$107M	Buy	2,216,553 +294,445	+15%	+$14.1M	0.13%	236
2019 Q1	$97.1M	Buy	1,922,108 +617,486	+47%	+$36.4M	0.12%	251
2018 Q4	$77.3M	Buy	1,304,622 +969,452	+289%	+$62.5M	0.11%	274
2018 Q3	$22.1M	Buy	+335,170	New	+$19.6M	0.03%	618